My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 47

    1.

    A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

    Zhang K, Wong P, Zhang L, Jacobs B, Borden EC, Aster JC, Bedogni B.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.606. [Epub ahead of print]

    PMID:
    22249266
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.

    Rodríguez MI, González-Flores A, Dantzer F, Collard J, de Herreros AG, Oliver FJ.

    Oncogene. 2011 Oct 20;30(42):4365-72. doi: 10.1038/onc.2011.153. Epub 2011 May 16.

    PMID:
    21577210
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway.

    Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C, Richmond A.

    Oncogene. 2012 May 17;31(20):2580-92. doi: 10.1038/onc.2011.427. Epub 2011 Oct 3.

    PMID:
    21963849
    [PubMed - in process]

    Related citations

    4.

    Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.

    Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, Ballotti R.

    Oncogene. 2012 May 10;31(19):2461-70. doi: 10.1038/onc.2011.425. Epub 2011 Sep 26.

    PMID:
    21996743
    [PubMed - in process]

    Related citations

    5.

    Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells.

    Basile KJ, Abel EV, Aplin AE.

    Oncogene. 2012 May 10;31(19):2471-9. doi: 10.1038/onc.2011.424. Epub 2011 Sep 26.

    PMID:
    21996740
    [PubMed - in process]

    Related citations

    6.

    Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.

    Li W, Melton DW.

    Oncogene. 2012 May 10;31(19):2412-22. doi: 10.1038/onc.2011.426. Epub 2011 Sep 26.

    PMID:
    21996734
    [PubMed - in process]

    Related citations

    7.

    c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.

    Ganguly SS, Fiore LS, Sims JT, Friend JW, Srinivasan D, Thacker MA, Cibull ML, Wang C, Novak M, Kaetzel DM, Plattner R.

    Oncogene. 2012 Apr 5;31(14):1804-16. doi: 10.1038/onc.2011.361. Epub 2011 Sep 5.

    PMID:
    21892207
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Erythropoietin receptor contributes to melanoma cell survival in vivo.

    Kumar SM, Zhang G, Bastian BC, Arcasoy MO, Karande P, Pushparajan A, Acs G, Xu X.

    Oncogene. 2012 Mar 29;31(13):1649-60. doi: 10.1038/onc.2011.366. Epub 2011 Aug 22.

    PMID:
    21860424
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.

    Streicher KL, Zhu W, Lehmann KP, Georgantas RW, Morehouse CA, Brohawn P, Carrasco RA, Xiao Z, Tice DA, Higgs BW, Richman L, Jallal B, Ranade K, Yao Y.

    Oncogene. 2012 Mar 22;31(12):1558-70. doi: 10.1038/onc.2011.345. Epub 2011 Aug 22.

    PMID:
    21860416
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers.

    Lee J, Li L, Gretz N, Gebert J, Dihlmann S.

    Oncogene. 2012 Mar 8;31(10):1242-53. doi: 10.1038/onc.2011.320. Epub 2011 Aug 1.

    PMID:
    21804607
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    11.

    IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.

    Oh JH, Cho MC, Kim JH, Lee SY, Kim HJ, Park ES, Ban JO, Kang JW, Lee DH, Shim JH, Han SB, Moon DC, Park YH, Yu DY, Kim JM, Kim SH, Yoon DY, Hong JT.

    Oncogene. 2011 Jul 28;30(30):3345-59. doi: 10.1038/onc.2011.52. Epub 2011 Mar 21.

    PMID:
    21423208
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    12.

    Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma.

    de Lange J, Ly LV, Lodder K, Verlaan-de Vries M, Teunisse AF, Jager MJ, Jochemsen AG.

    Oncogene. 2012 Mar 1;31(9):1105-16. doi: 10.1038/onc.2011.309. Epub 2011 Jul 18.

    PMID:
    21765463
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    E2F1-dependent oncogenic addiction of melanoma cells to MDM2.

    Verhaegen M, Checinska A, Riblett MB, Wang S, Soengas MS.

    Oncogene. 2012 Feb 16;31(7):828-41. doi: 10.1038/onc.2011.277. Epub 2011 Jul 11.

    PMID:
    21743494
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF.

    Xing F, Persaud Y, Pratilas CA, Taylor BS, Janakiraman M, She QB, Gallardo H, Liu C, Merghoub T, Hefter B, Dolgalev I, Viale A, Heguy A, De Stanchina E, Cobrinik D, Bollag G, Wolchok J, Houghton A, Solit DB.

    Oncogene. 2012 Jan 26;31(4):446-57. doi: 10.1038/onc.2011.250. Epub 2011 Jul 4.

    PMID:
    21725359
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration.

    Luo Y, Zheng C, Zhang J, Lu D, Zhuang J, Xing S, Feng J, Yang D, Yan X.

    Oncogene. 2012 Jan 19;31(3):306-21. doi: 10.1038/onc.2011.244. Epub 2011 Jul 4.

    PMID:
    21725352
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.

    Fenouille N, Puissant A, Tichet M, Zimniak G, Abbe P, Mallavialle A, Rocchi S, Ortonne JP, Deckert M, Ballotti R, Tartare-Deckert S.

    Oncogene. 2011 Dec 8;30(49):4887-900. doi: 10.1038/onc.2011.198. Epub 2011 Jun 20.

    PMID:
    21685937
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    EphA2 is a critical oncogene in melanoma.

    Udayakumar D, Zhang G, Ji Z, Njauw CN, Mroz P, Tsao H.

    Oncogene. 2011 Dec 15;30(50):4921-9. doi: 10.1038/onc.2011.210. Epub 2011 Jun 13.

    PMID:
    21666714
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma.

    Yang D, Tao J, Li L, Kedei N, Tóth ZE, Czap A, Velasquez JF, Mihova D, Michalowski AM, Yuspa SH, Blumberg PM.

    Oncogene. 2011 Nov 10;30(45):4590-600. doi: 10.1038/onc.2011.166. Epub 2011 May 23.

    PMID:
    21602881
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Error occurred: cannot get document summary

    PMID:
    21593736

    20.

    In melanoma, beta-catenin is a suppressor of invasion.

    Arozarena I, Bischof H, Gilby D, Belloni B, Dummer R, Wellbrock C.

    Oncogene. 2011 Nov 10;30(45):4531-43. doi: 10.1038/onc.2011.162. Epub 2011 May 16.

    PMID:
    21577209
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk